 |
|
roquinimex
A quinoline-3-carboxamide with potential antineoplastic activity. Roquinimex inhibits endothelial cell proliferation, migration, and basement membrane invasion; reduces the secretion of the angiogenic factor tumor necrosis factor alpha by tumor-associated macrophages (TAMs); and inhibits angiogenesis. This agent is also an immune modulator that appears to alter cytokine profiles and enhance the activity of T cells, natural killer cells, and macrophages. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Linomide | | | | Code names: | | FCF 89
LS 2616 | | | | Chemical structure names: | | - 1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-3-quinolinecarboxanilide
- 1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-3-quinolinecarboxamide
- N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide
| | |
| Previous: | Roferon-A, romidepsin, romiplostim, Romozin, ropivacaine hydrochloride | | Next: | rosiglitazone maleate, Roxanol, Roxicodone, Rozerem, RP-Mycin |
|
|
